US Patent Issued to CSPC Megalith Biopharmaceutical on July 14 for "Anti-claudin 18 antibodies and methods of use thereof" (Pennsylvania, New Jersey, California Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,890, issued on July 14, was assigned to CSPC Megalith Biopharmaceutical Co. Ltd. (Hebei, China).

"Anti-claudin 18 antibodies and methods of use thereof" was invented by Han Li (Newtown, Pa.), Ming Lei (Princeton, N.J.), Yi Pei (Paoli, Pa.) and Haichun Huang (Fremont, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies that specifically bind to the human tight junction molecule CLDN18.2 and have functional properties that make them suitable for use in antibody-based immunotherapies of a disease associated with aberrant expression of CLDN18.2 are disclosed."

The patent was filed on June 22, 2022, under Application No. 17/846,709.

*For f...